Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial

Matteo Della Porta, Guillermo Garcia‐Manero, Valeria Santini, Amer M. Zeidan, Rami S. Komrokji, Jake Shortt, David Valcárcel, Anna Jonášová, Sophie Dimicoli‐Salazar, Ing Soo Tiong,

The Lancet Haematology · 2024 · 48 citations · 18 references

Concepts

References

18